AGT and Dorfman-Chanarin disease: Additionally, by chronic administration of substances which inhibit either the formation of Ang II or its action on the vessels, or promotes vasomotion independently of the RAAS and NO-cGMP pathways, we aimed to confirm (i): whether the RAAS could be involved in the development of DCS and, if so, (ii): by which mechanisms.